<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36250059</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: New clues to long-term cognitive disorders.</ArticleTitle><Pagination><StartPage>905757</StartPage><MedlinePgn>905757</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">905757</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2022.905757</ELocationID><Abstract><AbstractText>In early 2020, one of the most prevalent symptoms of SARS-CoV-2 infection was the loss of smell (anosmia), found in 60-70% of all cases. Anosmia used to occur early, concomitantly with other symptoms, and often persisted after recovery for an extended period, sometimes for months. In addition to smell disturbance, COVID-19 has also been associated with loss of taste (ageusia). The latest research suggests that SARS-CoV-2 could spread from the respiratory system to the brain through receptors in sustentacular cells localized to the olfactory epithelium. The virus invades human cells <i>via</i> the obligatory receptor, angiotensin-converting enzyme II (ACE2), and a priming protease, TMPRSS2, facilitating viral penetration. There is an abundant expression of both <i>ACE2</i> and <i>TMPRSS2</i> in sustentacular cells. In this study, we evaluated 102 COVID-19 hospitalized patients, of which 17.60% presented anosmia and 9.80% ageusia. <i>ACE1</i>, <i>ACE2</i>, and <i>TMPRSS2</i> gene expression levels in nasopharyngeal tissue were obtained by RT-qPCR and measured using &#x394;CT analysis. ACE1 <i>Alu</i>287bp association was also evaluated. Logistic regression models were generated to estimate the effects of variables on ageusia and anosmia Association of <i>ACE2</i> expression levels with ageusia. was observed (OR: 1.35; 95% CI: 1.098-1.775); however, no association was observed between <i>TMPRSS2</i> and <i>ACE1</i> expression levels and ageusia. No association was observed among the three genes and anosmia, and the <i>Alu</i>287bp polymorphism was not associated with any of the outcomes. Lastly, we discuss whetherthere is a bridge linking these initial symptoms, including molecular factors, to long-term COVID-19 health consequences such as cognitive dysfunctions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Braga-Paz, Ferreira de Ara&#xfa;jo, Alves, de &#xc1;vila, Resende, Teixeira, de Aguiar, de Souza and Bahia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Braga-Paz</LastName><ForeName>Isabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira de Ara&#xfa;jo</LastName><ForeName>Jo&#xe3;o Locke</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Hugo Jos&#xe9;</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de &#xc1;vila</LastName><ForeName>Renata Eliane</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Hospital Eduardo de Menezes, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resende</LastName><ForeName>Gustavo Gomes</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Hospital das Cl&#xed;nicas, Universidade Federal de Minas Gerais (HC-UFMG/EBSERH), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Mauro Martins</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Departamento de Bioquimica e imunologia, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Aguiar</LastName><ForeName>Renato Santana</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto D'Or de Pesquisa e Ensino, Instituto D'OR (IDOR), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Renan Pedra</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahia</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica, Ecologia e Evolu&#xe7;&#xe3;o, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011945">Receptors, Angiotensin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="Y">Ageusia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011945" MajorTopicYN="N">Receptors, Angiotensin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ageusia</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">genetic association</Keyword><Keyword MajorTopicYN="N">long-COVID syndrome</Keyword><Keyword MajorTopicYN="N">quantitative trait</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36250059</ArticleId><ArticleId IdType="pmc">PMC9556632</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2022.905757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aghagoli G., Gallo Marin B., Katchur N. J., Chaves-Sell F., Asaad W. F., Murphy S. A. (2021). Neurological involvement in COVID-19 and potential mechanisms: A review. Neurocrit. Care 34, 1062&#x2013;1071. doi:&#xa0;10.1007/s12028-020-01049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-01049-4</ArticleId><ArticleId IdType="pmc">PMC7358290</ArticleId><ArticleId IdType="pubmed">32661794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A. K., Sayad R., Mahmoud I. A., EL-Monem A. M. A., Badry S. H., Ibrahim I. H., et al. . (2022). &#x201c;Anosmia&#x201d; the mysterious collateral damage of COVID-19. J. Neurovirol. 28(2), 189&#x2013;200. doi:&#xa0;10.1007/s13365-022-01060-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01060-9</ArticleId><ArticleId IdType="pmc">PMC8898086</ArticleId><ArticleId IdType="pubmed">35249186</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R. C. (2021). COVID-19 and its sequelae: A platform for optimal patient care, discovery and training. J. Thromb. Thrombolysis 51, 587&#x2013;594. doi:&#xa0;10.1007/s11239-021-02375-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02375-w</ArticleId><ArticleId IdType="pmc">PMC7838017</ArticleId><ArticleId IdType="pubmed">33501596</ArticleId></ArticleIdList></Reference><Reference><Citation>Brechb&#xfc;hl J., Lopes A. C., Wood D., Bouteiller S., de Valli&#xe8;re A., Verdumo C., et al. . (2021). Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms. Commun. Biol. 4, 1&#x2013;12. doi:&#xa0;10.1038/s42003-021-02410-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02410-9</ArticleId><ArticleId IdType="pmc">PMC8282876</ArticleId><ArticleId IdType="pubmed">34267318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso C. C., Rossi &#xc1;. D., Galliez R. M., Faffe D. S., Tanuri A., Casti&#xf1;eiras T. M. P. P. (2022). Olfactory dysfunction in patients with mild COVID-19 during gamma, delta, and omicron waves in Rio de Janeiro, Brazil. JAMA 328(6), 582&#x2013;583. doi:&#xa0;10.1001/jama.2022.11006</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11006</ArticleId><ArticleId IdType="pmc">PMC9364123</ArticleId><ArticleId IdType="pubmed">35749125</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellon R., Hamdi H. (2007). Demystifying the ACE polymorphism: From genetics to biology. Curr. Pharm. Des. 13, 1191&#x2013;1198. doi:&#xa0;10.2174/138161207780618902</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161207780618902</ArticleId><ArticleId IdType="pubmed">17504229</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzolla A. P., Lovero R., Lo Muzio L., Testa N. F., Schirinzi A., Palmieri G., et al. . (2020). Taste and smell disorders in COVID-19 patients: Role of interleukin-6. ACS Chem. Neurosci. 11, 2774&#x2013;2781. doi:&#xa0;10.1021/acschemneuro.0c00447</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00447</ArticleId><ArticleId IdType="pubmed">32786309</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J. Y., Smith D. M. (2021). SARS-CoV-2 variants of concern. Yonsei Med. J. 62, 961&#x2013;968. doi:&#xa0;10.3349/ymj.2021.62.11.961</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2021.62.11.961</ArticleId><ArticleId IdType="pmc">PMC8542474</ArticleId><ArticleId IdType="pubmed">34672129</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S., Sreenivasulu K., Mitra P., Misra S., Sharma P. (2020). Role of genetic variants and gene expression in the susceptibility and severity of COVID-19. Ann. Lab. Med. 41, 129&#x2013;138. doi:&#xa0;10.3343/alm.2021.41.2.129</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2021.41.2.129</ArticleId><ArticleId IdType="pmc">PMC7591285</ArticleId><ArticleId IdType="pubmed">33063674</ArticleId></ArticleIdList></Reference><Reference><Citation>Conde Cardona G., Quintana P&#xe1;jaro L. D., Quintero Marzola I. D., Ramos Villegas Y., Moscote Salazar L. R. (2020). Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J. Neurol. Sci. 412, 116824. doi:&#xa0;10.1016/j.jns.2020.116824</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116824</ArticleId><ArticleId IdType="pmc">PMC7141641</ArticleId><ArticleId IdType="pubmed">32299010</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;ardes D., Boccatonda A., Rossi I., Guagnano M. T., Santilli F., Cipollone F., et al. . (2020). COVID-19 and RAS: Unravelling an unclear relationship. Int. J. Mol. Sci. 21, 1&#x2013;8. doi:&#xa0;10.3390/ijms21083003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21083003</ArticleId><ArticleId IdType="pmc">PMC7215550</ArticleId><ArticleId IdType="pubmed">32344526</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ara&#xfa;jo J. L. F., Menezes D., de Aguiar R. S., de Souza R. P. (2022). IFITM3, FURIN, ACE1, and TNF-&#x3b1; genetic association with COVID-19 outcomes: Systematic review and meta-analysis. Front. Genet. 13. doi:&#xa0;10.3389/fgene.2022.775246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.775246</ArticleId><ArticleId IdType="pmc">PMC9010674</ArticleId><ArticleId IdType="pubmed">35432458</ArticleId></ArticleIdList></Reference><Reference><Citation>de Paula J. J., Paiva R. E. R. P., Souza-Silva N. G., Rosa D. V., Duran F. L., de S., et al. . (2022). Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings. Mol. Psychiatry. doi:&#xa0;10.1038/s41380-022-01632-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01632-5</ArticleId><ArticleId IdType="pmc">PMC9196149</ArticleId><ArticleId IdType="pubmed">35701598</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. . (2022). SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature 604, 697&#x2013;707. doi:&#xa0;10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Farid H., Khan M., Jamal S., Ghafoor R. (2022). Oral manifestations of covid-19-A literature review. Rev. Med. Virol. 32, 1&#x2013;12. doi:&#xa0;10.1002/rmv.2248</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2248</ArticleId><ArticleId IdType="pmc">PMC8209937</ArticleId><ArticleId IdType="pubmed">34028129</ArticleId></ArticleIdList></Reference><Reference><Citation>Galisa S. L. G., Almeida R. M., de S., Soares A. R. A. P., Ribeiro R. R. A., Pereira F. R. A., et al. . (2021). Influ&#xea;ncia da suscetibilidade gen&#xe9;tica na incid&#xea;ncia e mortalidade de COVID-19 (SARS-CoV-2). Res. Soc Dev. 10, e31810111812. doi:&#xa0;10.33448/rsd-v10i1.11812</Citation><ArticleIdList><ArticleId IdType="doi">10.33448/rsd-v10i1.11812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghamrawi R., Gunaratne M. (2020). COVID-19 and sex differences. Mayo Clin. Proc. 95, 2189&#x2013;2203. doi:&#xa0;10.1016/j.mayocp.2020.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7402208</ArticleId><ArticleId IdType="pubmed">33012349</ArticleId></ArticleIdList></Reference><Reference><Citation>Glezer I., Bruni-Cardoso A., Schechtman D., Malnic B. (2021). Viral infection and smell loss: The case of COVID-19. J. Neurochem. 157, 930&#x2013;943. doi:&#xa0;10.1111/jnc.15197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15197</ArticleId><ArticleId IdType="pmc">PMC7537178</ArticleId><ArticleId IdType="pubmed">32970861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Surda P., Whitehead E., Kumar B. N. (2020). Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J. Otolaryngol. Head Neck Surg. 49, 1&#x2013;6. doi:&#xa0;10.1186/s40463-020-00423-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40463-020-00423-8</ArticleId><ArticleId IdType="pmc">PMC7196882</ArticleId><ArticleId IdType="pubmed">32366299</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. . (2020). Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet 395, 497&#x2013;506. doi:&#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A., Ragusa M. A., Tortosa F., Lavena Marzio M. A., Agnoletti C., Bengolea A., et al. . (2020). Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PloS One 223(6), 945&#x2013;956. doi:&#xa0;10.1371/journal.pone.0241955</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241955</ArticleId><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Izurieta H. S., Graham D. J., Jiao Y., Hu M., Lu Y., Wu Y., et al. . (2020). Natural history of coronavirus disease 2019: Risk factors for hospitalizations and deaths among &lt;26 million US Medicare beneficiaries. J. Infect. Dis. doi:&#xa0;10.1093/infdis/jiaa767</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa767</ArticleId><ArticleId IdType="pmc">PMC7799044</ArticleId><ArticleId IdType="pubmed">33325510</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B. A., Xie X., Bailey A. L., Kalveram B., Lokugamage K. G., Muruato A., et al. . (2021). Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature 591, 293&#x2013;299. doi:&#xa0;10.1038/s41586-021-03237-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03237-4</ArticleId><ArticleId IdType="pmc">PMC8175039</ArticleId><ArticleId IdType="pubmed">33494095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J. R., Chiesa-Estomba C. M., De Siati D. R., Horoi M., Le Bon S. D., Rodriguez A., et al. . (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Oto-Rhino-Laryngol. 277, 2251&#x2013;2261. doi:&#xa0;10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. (2022). COVID and smell loss: Answers begin to emerge. Nature. 606(7915), 631&#x2013;632. doi:&#xa0;10.1038/d41586-022-01589-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01589-z</ArticleId><ArticleId IdType="pubmed">35681006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-G&#xf3;mez L. E., Herrera-L&#xf3;pez B., Martinez-Armenta C., Ortega-Pe&#xf1;a S., Camacho-Rea M., del C., et al. . (2022). ACE and ACE2 gene variants are associated with severe outcomes of COVID-19 in men. Front. Immunol. 13. doi:&#xa0;10.3389/fimmu.2022.812940</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.812940</ArticleId><ArticleId IdType="pmc">PMC8892378</ArticleId><ArticleId IdType="pubmed">35250987</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. . (2021). Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 24, 168&#x2013;175. doi:&#xa0;10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X., Pan Y. (2021). COVID-19 and anosmia: The story so far. Ear Nose Throat J. 0, 1&#x2013;9. doi:&#xa0;10.1177/01455613211048998</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211048998</ArticleId><ArticleId IdType="pubmed">34587819</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P., Barmania F., Mellet J., Peta K., Strydom A., Viljoen I. M., et al. . (2021). SARS-CoV-2 variants, vaccines, and host immunity. Front. Immunol. 12. doi:&#xa0;10.3389/fimmu.2021.809244</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.809244</ArticleId><ArticleId IdType="pmc">PMC8761766</ArticleId><ArticleId IdType="pubmed">35046961</ArticleId></ArticleIdList></Reference><Reference><Citation>Muus C., Luecken M. D., Eraslan G., Sikkema L., Waghray A., Heimberg G., et al. . (2021). Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nature Medicine. 27, 546&#x2013;559 .doi:&#xa0;10.1038/s41591-020-01227-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01227-z</ArticleId><ArticleId IdType="pmc">PMC9469728</ArticleId><ArticleId IdType="pubmed">33654293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S. N. (2021). Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw. Open 4, 1&#x2013;19. doi:&#xa0;10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G., Bertelloni D., Diolaiuti F., Mucci F., Di Giuseppe M., Biella M., et al. . (2021). Long-covid syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthc 9, 1&#x2013;15. doi:&#xa0;10.3390/healthcare9050575</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedro N., Silva C. N., Magalh&#xe3;es A. C., Cavadas B., Rocha A. M., Moreira A. C., et al. . (2021). Dynamics of a dual SARS-CoV-2 lineage Co-infection on a prolonged viral shedding COVID-19 case: Insights into clinical severity and disease duration. Microorganisms 9(2), 300. doi:&#xa0;10.3390/microorganisms9020300</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020300</ArticleId><ArticleId IdType="pmc">PMC7912897</ArticleId><ArticleId IdType="pubmed">33540596</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Patel K. J., Ranjan K. (2021). COVID-19: Unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies. Biomolecules 11(7), 993. doi:&#xa0;10.3390/biom11070993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070993</ArticleId><ArticleId IdType="pmc">PMC8301790</ArticleId><ArticleId IdType="pubmed">34356617</ArticleId></ArticleIdList></Reference><Reference><Citation>Riel D., Verdijk R., Kuiken T. (2015). The olfactory nerve: A shortcut for influenza and other viral diseases into the central nervous system. J. Pathol. 235, 277&#x2013;287. doi:&#xa0;10.1002/path.4461</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4461</ArticleId><ArticleId IdType="pubmed">25294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi &#xc1;. D., de Ara&#xfa;jo J. L. F., de Almeida T. B., Ribeiro-Alves M., de Almeida Velozo C., Almeida J. M., et al. . (2021). Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress. Sci. Rep. 11(1), 9658. doi:&#xa0;10.1038/s41598-021-88944-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88944-8</ArticleId><ArticleId IdType="pmc">PMC8102547</ArticleId><ArticleId IdType="pubmed">33958627</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad H., Jabotian K., Sakr C., Mahfouz R., Akl I. B., Zgheib N. K. (2021). The role of angiotensin converting enzyme 1 Insertion/Deletion genetic polymorphism in the risk and severity of COVID-19 infection. Front. Med. 8. doi:&#xa0;10.3389/fmed.2021.798571</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.798571</ArticleId><ArticleId IdType="pmc">PMC8733297</ArticleId><ArticleId IdType="pubmed">35004773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., Gambardella J., Morelli M. B., Wang X., Marfella R., Santulli G. (2020). Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J. Clin. Med. 9(5), 1417. doi:&#xa0;10.3390/jcm9051417</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051417</ArticleId><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. . (2021). Attributes and predictors of long-COVID. Nat. Med. 27, 626&#x2013;631. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R., da Cunha T. R., dos Santos Silva L. D., Ferreira C. S., Silva C. P., Ribeiro A. P., et al. . (2022). Persistent, new-onset symptoms and mental health complaints in long-COVID in a Brazilian cohort of non-hospitalized patients. BMC Infect. Dis. 22, 1&#x2013;11. doi:&#xa0;10.1186/s12879-022-07065-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K. L., Hummel T. (2020). Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA J. Am. Med. Assoc. 323, 2512&#x2013;2514. doi:&#xa0;10.1001/jama.2020.8391</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8391</ArticleId><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N., Saghazadeh A., Rezaei N. (2020). Anosmia: A missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev. Neurosci. 31, 691&#x2013;701. doi:&#xa0;10.1515/revneuro-2020-0039</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0039</ArticleId><ArticleId IdType="pubmed">32776905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska J. B., Lagodzinski A., Berezinska M. (2021). COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment. J. Physiol. Pharmacol. Off. J. Polish Physiol. Soc 72(4), 479&#x2013;501. doi:&#xa0;10.26402/jpp.2021.4.01</Citation><ArticleIdList><ArticleId IdType="doi">10.26402/jpp.2021.4.01</ArticleId><ArticleId IdType="pubmed">34987123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong M., Lin B., Pathak J. L., Gao H., Young A. J., Wang X., et al. . (2020). ACE2 and furin expressions in oral epithelial cells possibly facilitate COVID-19 infection via respiratory and fecal&#x2013;oral routes. Front. Med. 7. doi:&#xa0;10.3389/fmed.2020.580796</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.580796</ArticleId><ArticleId IdType="pmc">PMC7758442</ArticleId><ArticleId IdType="pubmed">33363183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>